Active substances
Betamethasone + Clotrimazole
- SFDA 4
- US FDA 8
- Health Canada 2
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| OPIZOLE-B CREAM | 1,0.05 % (W/W),% (W/W) | Cream · Topical | 1 Tube | SAR 11.00 | Generic · Prescription | OMAN PHARMACEUTICAL PRODUCTS | Valid |
| LOTRIDERM CREAM | 0.05, 1 % | Cream · Topical | 1 Tube | SAR 7.40 | NCE · Prescription | SCHERING-PLOUGH | Withdrawn by MAH · Not Marketed |
| LOTRIDERM CREAM | 0.05, 1 % | Cream · Topical | 1 Tube | SAR 14.80 | NCE · Prescription | Organon Belgium | Withdrawn by MAH · Not Marketed |
| LOTRIDERM CREAM | 0.05, 1 % | Cream · Topical | 1 Tube | SAR 21.90 | NCE · Prescription | SCHERING-PLOUGH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF VULVA AND VAGINA & CANDIDIASIS OF OTHER UROGENITAL SITES
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | cream · topical | TARO | Prescription | 29 May 2001 |
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | cream · topical | FOUGERA PHARMS | Prescription | 5 Jun 2001 |
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | cream · topical | ACTAVIS MID ATLANTIC | Prescription | 2 Aug 2002 |
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | lotion · topical | SUN PHARMA CANADA | Prescription | 28 Jul 2004 |
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | lotion · topical | FOUGERA PHARMS | Prescription | 16 Jun 2005 |
| LOTRISONE | EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream · topical | ORGANON | Discontinued | 10 Jul 1984 |
| LOTRISONE | EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | lotion · topical | MERCK SHARP DOHME | Discontinued | 8 Dec 2000 |
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE;1% | cream · topical | GLENMARK SPECLT | Discontinued | 30 Oct 2015 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| LOTRIDERM | 00611174 | 0.05 %; 1 % | CREAM · TOPICAL | ORGANON CANADA INC. |
| TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE | 02496410 | 1 % / W/W; 0.05 % / W/W | CREAM · TOPICAL | TARO PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Betamethasone dipropionate 0.064% / Clotrimazole 1% cream | £6.34 | 30 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.